학술논문
Phase II clinical trial with metronomic oral vinorelbine and tri-weekly cisplatin as induction therapy, subsequently concomitant with radiotherapy (RT) in patients with locally advanced, unresectable, non-small cell lung cancer (NSCLC). Analysis of survival and value of ctDNA for patient selection
Document Type
Journal
Author
Provencio, Mariano; Majem, Margarita; Guirado, Maria; Massuti, Bartomeu; de Las Penas, Ramon; Laura Ortega, Ana; Domine, Manuel; Marse, Raquel; Angeles Sala, Maria; Paredes, Alfredo; Moran, Teresa; Vazquez, Sergio; Coves, Juan; Gonzalez Larriba, Jose Luis; Miguel Sanchez, Jose; Vicente, David; Farre, Nuria; Fernandez Fornos, Luis; Zapata, Irma; Franco, Fabio; Serna-Blasco, Roberto; Romero, Atocha; Isla, Dolores
Source
Subject
Language
English
ISSN
18728332